Literature DB >> 25516542

Vif determines the requirement for CBF-β in APOBEC3 degradation.

Rokusuke Yoshikawa1, Junko S Takeuchi1, Eri Yamada1, Yusuke Nakano2,1, Fengrong Ren3, Hiroshi Tanaka3, Carsten Münk4, Reuben S Harris5, Takayuki Miyazawa6,7, Yoshio Koyanagi1, Kei Sato8,1.   

Abstract

APOBEC3 (apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3) proteins are cellular DNA deaminases that restrict a broad spectrum of lentiviruses. This process is counteracted by Vif (viral infectivity factor) of lentiviruses, which binds APOBEC3s and promotes their degradation. CBF-β (core binding factor subunit β) is an essential co-factor for the function of human immunodeficiency virus type 1 Vif to degrade human APOBEC3s. However, the requirement for CBF-β in Vif-mediated degradation of other mammalian APOBEC3 proteins is less clear. Here, we determined the sequence of feline CBFB and performed phylogenetic analyses. These analyses revealed that mammalian CBFB is under purifying selection. Moreover, we demonstrated that CBF-β is dispensable for feline immunodeficiency virus Vif-mediated degradation of APOBEC3s of its host. These findings suggested that primate lentiviruses have adapted to use CBF-β, an evolutionary stable protein, to counteract APOBEC3 proteins of their hosts after diverging from other lentiviruses.
© 2015 The Authors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25516542      PMCID: PMC4361795          DOI: 10.1099/jgv.0.000027

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  39 in total

1.  HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.

Authors:  Judd F Hultquist; Rebecca M McDougle; Brett D Anderson; Reuben S Harris
Journal:  AIDS Res Hum Retroviruses       Date:  2012-08-13       Impact factor: 2.205

2.  Datamonkey: rapid detection of selective pressure on individual sites of codon alignments.

Authors:  Sergei L Kosakovsky Pond; Simon D W Frost
Journal:  Bioinformatics       Date:  2005-02-15       Impact factor: 6.937

Review 3.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

Review 4.  Function of CBFbeta/Bro proteins.

Authors:  N Adya; L H Castilla; P P Liu
Journal:  Semin Cell Dev Biol       Date:  2000-10       Impact factor: 7.727

5.  GUIDANCE: a web server for assessing alignment confidence scores.

Authors:  Osnat Penn; Eyal Privman; Haim Ashkenazy; Giddy Landan; Dan Graur; Tal Pupko
Journal:  Nucleic Acids Res       Date:  2010-05-23       Impact factor: 16.971

6.  Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity.

Authors:  Rebecca S Larue; Joy Lengyel; Stefán R Jónsson; Valgerdur Andrésdóttir; Reuben S Harris
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

7.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

Review 8.  Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Authors:  John S Albin; Reuben S Harris
Journal:  Expert Rev Mol Med       Date:  2010-01-22       Impact factor: 5.600

9.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.

Authors:  Hui Zhang; Bin Yang; Roger J Pomerantz; Chune Zhang; Shyamala C Arunachalam; Ling Gao
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

Review 10.  Suppression of APOBEC3-mediated restriction of HIV-1 by Vif.

Authors:  Yuqing Feng; Tayyba T Baig; Robin P Love; Linda Chelico
Journal:  Front Microbiol       Date:  2014-08-26       Impact factor: 5.640

View more
  14 in total

1.  Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.

Authors:  Qinyong Gu; Zeli Zhang; Lucía Cano Ortiz; Ana Cláudia Franco; Dieter Häussinger; Carsten Münk
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 2.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

3.  Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.

Authors:  Zeli Zhang; Qinyong Gu; Ananda Ayyappan Jaguva Vasudevan; Manimehalai Jeyaraj; Stanislaw Schmidt; Jörg Zielonka; Mario Perković; Jens-Ove Heckel; Klaus Cichutek; Dieter Häussinger; Sander H J Smits; Carsten Münk
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

4.  A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.

Authors:  Sizhu Duan; Shiqi Wang; Yanan Song; Nan Gao; Lina Meng; Yanxin Gai; Ying Zhang; Song Wang; Chu Wang; Bin Yu; Jiaxin Wu; Xianghui Yu
Journal:  J Biol Chem       Date:  2020-08-19       Impact factor: 5.157

5.  Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.

Authors:  Qinyong Gu; Zeli Zhang; Christoph G W Gertzen; Dieter Häussinger; Holger Gohlke; Carsten Münk
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 6.  Evolutionary Paradigms from Ancient and Ongoing Conflicts between the Lentiviral Vif Protein and Mammalian APOBEC3 Enzymes.

Authors:  Reuben S Harris; Brett D Anderson
Journal:  PLoS Pathog       Date:  2016-12-01       Impact factor: 6.823

7.  Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3.

Authors:  Rokusuke Yoshikawa; Junko S Takeuchi; Eri Yamada; Yusuke Nakano; Naoko Misawa; Yuichi Kimura; Fengrong Ren; Takayuki Miyazawa; Yoshio Koyanagi; Kei Sato
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

8.  Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors.

Authors:  Zeli Zhang; Qinyong Gu; Ananda Ayyappan Jaguva Vasudevan; Anika Hain; Björn-Philipp Kloke; Sascha Hasheminasab; Daniel Mulnaes; Kei Sato; Klaus Cichutek; Dieter Häussinger; Ignacio G Bravo; Sander H J Smits; Holger Gohlke; Carsten Münk
Journal:  Retrovirology       Date:  2016-07-01       Impact factor: 4.602

9.  Species-specific differences in the ability of feline lentiviral Vif to degrade feline APOBEC3 proteins.

Authors:  Rokusuke Yoshikawa; Yusuke Nakano; Eri Yamada; Taisuke Izumi; Naoko Misawa; Yoshio Koyanagi; Kei Sato
Journal:  Microbiol Immunol       Date:  2016-04       Impact factor: 1.955

10.  A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.

Authors:  Rokusuke Yoshikawa; Taisuke Izumi; Eri Yamada; Yusuke Nakano; Naoko Misawa; Fengrong Ren; Michael A Carpenter; Terumasa Ikeda; Carsten Münk; Reuben S Harris; Takayuki Miyazawa; Yoshio Koyanagi; Kei Sato
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.